Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
Details for Australian Patent Application No. 2004253888 (hide)
International Classifications
Event Publications
22 December 2005 PCT application entered the National Phase
PCT publication WO2005/003096 Priority application(s): WO2005/003096
11 November 2010 Application Accepted
Published as AU-B-2004253888
10 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004253889-Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
2004253884-SPPLs as modifiers of the p53 pathway and methods of use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser